[1]
J. R. C. Pandey, G. N. Vyas, E. H. Dutta, S. K. Shah, and H. J. Patel, “A comprehensive review of biomarker-based therapies for hormone receptor-positive and HER2-low breast cancer: clinical pharmacists’ implications”, Int J Basic Clin Pharmacol, vol. 15, no. 3, pp. 589–593, Apr. 2026.